Effect of therapeutic hypothermia vs δ-opioid receptor agonist on post resuscitation myocardial function in a rat model of CPR

Resuscitation

Volumn 82, Issue 3, 2011, Pages 350-354

  Chung, Sung Phil ^a,b   Song, Feng Qing ^a   Yu, Tao ^a   Weng, Yinlun ^a   Sun, Shijie ^a,c   Weil, Max Harry ^a,c   Tang, Wanchun ^a,c  

^a INSTITUTE OF CRITICAL CARE MEDICINE   (United States)

^b Yonsei University College of Medicine   (South Korea)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cardiac arrest; Cardiopulmonary resuscitation; Delta opioid receptor; Hypothermia

Indexed keywords

DELTA OPIATE RECEPTOR AGONIST; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE];

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART OUTPUT; HEART PERFORMANCE; HEART VENTRICLE FIBRILLATION; INDUCED HYPOTHERMIA; INFUSION PUMP; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RESUSCITATION; SURVIVAL TIME;

ANIMALS; CARDIOPULMONARY RESUSCITATION; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; ENKEPHALIN, LEUCINE-2-ALANINE; HEART; HYPOTHERMIA, INDUCED; INFUSIONS, INTRAVENOUS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, DELTA; STROKE VOLUME;

EID: 79751530538     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2010.11.010     Document Type: Article

References (31)

1. Polderman K.H. Mechanisms of action, physiological effects, and complications of hypothermia. Crit Care Med 2009, 37:S186-202.
2. Zhao Z.Q., Corvera J.S., Halkos M.E., et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003, 285:H579-H588.
3. Wang J.Y., Shen J., Gao Q., et al. Ischemic postconditioning protects against global cerebral ischemia/reperfusion-induced injury in rats. Stroke 2008, 39:983-990.
4. Wong G.T., Li R., Jiang L.L., Irwin M.G. Remifentanil post-conditioning attenuates cardiac ischemia-reperfusion injury via kappa or delta opioid receptor activation. Acta Anaesthesiol Scand 2010, 25:75-79.
5. Oeltgen P.R., Nilekani S.P., Nuchols P.A., Spurrier W.A., Su T.P. Further studies on opioids and hibernation: delta opioid receptor ligand selectively induced hibernation in summer-active ground squirrels. Life Sci 1988, 43:1565-1574.
6. Rosen C.L., Cote A., Haddad G.G. Effect of enkephalins on cardiac output and regional blood flow in conscious dogs. Am J Physiol 1989, 256:H1651-H1658.
7. Förster K., Kuno A., Solenkova N., Felix S.B., Krieg T. The delta-opioid receptor agonist DADLE at reperfusion protects the heart through activation of pro-survival kinases via EGF receptor transactivation. Am J Physiol Heart Circ Physiol 2007, 293:H1604-H1608.
8. Sigg D.C., Coles J.A., Gallagher W.J., Oeltgen P.R., Iaizzo P.A. Opioid preconditioning: myocardial function and energy metabolism. Ann Thorac Surg 2001, 72:1576-1582.
9. Borlongan C.V., Hayashi T., Oeltgen P.R., Su T.P., Wang Y. Hibernation-like state induced by an opioid peptide protects against experimental stroke. BMC Biol 2009, 7:31.
10. Borlongan C.V., Su T.P., Wang Y. Treatment with delta opioid peptide enhances in vitro and in vivo survival of rat dopaminergic neurons. Neuroreport 2000, 11:923-926.
11. Hayashi T., Hirata H., Asanuma M., et al. Delta opioid peptide (d-Ala2, d-Leu5) enkephalin causes a near complete blockade of the neuronal damage caused by a single high dose of methamphetamine: examining the role of p53. Synapse 2001, 39:305-312.
12. Tubbs R.J., Porcaro W.A., Lee W.J., et al. Delta opiates increase ischemic tolerance in isolated rabbit jejunum. Acad Emerg Med 2002, 9:555-560.
13. Yamanouchi K., Yanaga K., Okudaira S., Eguchi S., Furui J., Kanematsu T. (d-Ala2, d-Leu5) enkephalin (DADLE) protects liver against ischemia-reperfusion injury in the rat. J Surg Res 2003, 114:72-77.
14. Wu G., Zhang F., Salley R.K., Diana J.N., Su T.P., Chien S. Delta opioid extends hypothermic preservation time of the lung. J Thorac Cardiovasc Surg 1996, 111:259-267.
15. Gao C.J., Li J.P., Wang W., et al. Effects of intracerebroventricular application of the delta opioid receptor agonist (d-Ala2, d-Leu5) enkephalin on neurological recovery following asphyxial cardiac arrest in rats. Neuroscience 2010, 168:531-542.
16. Tang W., Weil M.H., Sun S., et al. KATP channel activation reduces the severity of postresuscitation myocardial dysfunction. Am J Physiol Heart Circ Physiol 2000, 279:H1609-H1615.
17. Ikeda Y., Miura T., Sakamoto J., et al. Activation of ERK and suppression of calcineurin are interacting mechanisms of cardioprotection afforded by delta-opioid receptor activation. Basic Res Cardiol 2006, 101:418-426.
18. Neumar R.W., Bircher N.G., Sim K.M., et al. Epinephrine and sodium bicarbonate during CPR following asphyxial cardiac arrest in rats. Resuscitation 1995, 29:249-263.
19. Tei C. New non-invasive index for combined systolic and diastolic ventricular function. J Cardiol 1995, 26:135-136.
20. Meybohm P., Gruenewald M., Albrecht M., et al. Hypothermia and postconditioning after cardiopulmonary resuscitation reduce cardiac dysfunction by modulating inflammation, apoptosis and remodeling. PLoS One 2009, 4:e7588.
21. Huh J., Gross G.J., Nagase H., Liang B.T. Protection of cardiac myocytes via delta(1)-opioid receptors, protein kinase C, and mitochondrial K(ATP) channels. Am J Physiol Heart Circ Physiol 2001, 280:H377-H383.
22. Rutten M., Govindaswami M., Oeltgen P., Sonneborn J.S. Post-treatment with the novel deltorphin E, a delta2-opioid receptor agonist, increases recovery and survival after severe hemorrhagic shock in behaving rats. Shock 2008, 29:42-48.
23. Drabek T., Han F., Garman R.H., et al. Assessment of the delta opioid agonist DADLE in a rat model of lethal hemorrhage treated by emergency preservation and resuscitation. Resuscitation 2008, 77:220-228.
24. Iwata M., Inoue S., Kawaguchi M., Nakamura M., Konishi N., Furuya H. Effects of delta-opioid receptor stimulation and inhibition on hippocampal survival in a rat model of forebrain ischaemia. Br J Anaesth 2007, 99:538-546.
25. Watson M.J., Holt J.D., O'Neill S.J., et al. ARD-353 (4-((2R,5S)-4-(R)-(4-diethylcarbamoylphenyl)(3-hydroxyphenyl)methyl)-2,5-dimethylpiperazin-1-ylmethyl)benzoic acid), a novel nonpeptide delta receptor agonist, reduces myocardial infarct size without central effects. J Pharmacol Exp Ther 2006, 316:423-430.
26. Gross E.R., Peart J.N., Hsu A.K., Auchampach J.A., Gross G.J. Extending the cardioprotective window using a novel delta-opioid agonist fentanyl isothiocyanate via the PI3-kinase pathway. Am J Physiol Heart Circ Physiol 2005, 288:H2744-H2749.
27. Gross E.R., Gross G.J. Ligand triggers of classical preconditioning and postconditioning. Cardiovasc Res 2006, 70:212-221.
28. Yang Y., Xia X., Zhang Y., et al. Delta-opioid receptor activation attenuates oxidative injury in the ischemic rat brain. BMC Biol 2009, 7:55.
29. Su D.S., Wang Z.H., Zheng Y.J., Zhao Y.H., Wang X.R. Dose-dependent neuroprotection of delta opioid peptide (d-Ala2, d-Leu5) enkephalin in neuronal death and retarded behavior induced by forebrain ischemia in rats. Neurosci Lett 2007, 423:113-117.
30. Yang J.Z., Chen W., Borchardt R.T. In vitro stability and in vivo pharmacokinetic studies of a model opioid peptide, H-Tyr-d-Ala-Gly-Phe-d-Leu-OH (DADLE), and its cyclic prodrugs. J Pharmacol Exp Ther 2002, 303:840-848.
31. Iwata M., Inoue S., Kawaguchi M., et al. Delta opioid receptors stimulation with (d-Ala2, d-Leu5) enkephalin does not provide neuroprotection in the hippocampus in rats subjected to forebrain ischemia. Neurosci Let 2007, 414:242-246.